Treatment of intertrigo: zinc oxide in ketoconazolecream with or without substitution of hydrocortisone
- Conditions
- Patients with intertrigo in the large skin folds as the groin, submammary and axillairy will be included for a medical trial. The intertrigo has to be two-sided, so each patient can be his own controle.
- Registration Number
- EUCTR2006-006234-18-NL
- Lead Sponsor
- Medisch Centrum Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
- Two-sided intertrigo in the groin, submammary or axillary that has not been treated yet.
- After 5-7 days a revision should be possible.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
- Patients may not have an affection that can be of influence for this treatment or an affection wherefor our threament has an contra-indication.
- Patients can't have an hypersensibility for the given treatment
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Reduce of area of intertrigo;Secondary Objective: reduce of local complainments checked by a scoreform and evaluation of the cultured samples taken with inclusion.;Primary end point(s): Reduce of the intertigo area
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.